Cigarette smoking behavior is influenced by both personality traits and inherited factors. Previous research showed that neuroticism-a broad personality domain that includes anxiety, depression, impulsiveness and vulnerability-increases the risk of being a smoker, primarily because of difficulty in quitting. Neuroticism has also been associated with the 5-HTTLPR, a functional polymorphism in the promoter for the serotonin transporter gene. We used population and family-based methods to analyze the joint effects of the 5-HTTLPR and neuroticism on smoking behavior in a population of 759 never, current, and former smokers, all members of sib-pairs. Our main finding is that smoking behavior is influenced by an interaction between neuroticism and 5-HTTLPR genotype. Specifically, neuroticism was positively correlated with current smoking and negatively associated with smoking cessation in individuals and siblings with poorly transcribed 5-HTTLPR-S genotypes, but not in those with the more highly expressed 5-HTTLPR-L genotype. Individuals with both a 5-HTTLPR-S genotype and a high level of neuroticism had the greatest difficulty in quitting smoking. These data, if replicated, suggest that smoking behavior is more strongly influenced by the combination of the serotonin transporter gene and neuroticism than by either factor alone, and that personality scores and 5-HTTLPR genotype may predict the clinical efficacy of certain smoking cessation drugs. Molecular Psychiatry (2000) 5, 181-188.
Introduction
Cigarette smoking is the major preventable cause of premature mortality and morbidity in the United States. Although most smokers would like to quit, few succeed; even with behavioral counseling and pharmacological intervention, abstinence rates after 1 year are rarely greater than 30%. Part of the reason for the low success rates of smoking cessation programs is that they usually rely on a 'one size fits all' strategy that fails to take into account individual differences in smoking motives and behaviors. In fact, people start and continue to smoke for different reasons. Discovering the factors responsible for such individual differences is essential for developing more specifically targeted smoking intervention programs and drugs. 1, 2 Personality traits [3] [4] [5] [6] and genes [7] [8] [9] are two of the factors that contribute to smoking behavior. The present study examines the role of the one particular personality trait, neuroticism, and of one gene, the serotonin transporter locus, in starting and quitting smoking.
Neuroticism is a broadly defined domain of person- ality that encompasses various aspects of negative affect and emotionality such as depression, anxiety, hostility, impulsiveness, and vulnerability to stress. 10 Previous studies have shown that individuals with high levels of neuroticism have an increased likelihood of smoking and nicotine dependence and a decreased probability of smoking cessation. [11] [12] [13] Moreover major depression, which is a clinical correlate of high neuroticism, has been linked to an inability to stop smoking and relapse into smoking in both cross-sectional and prospective studies. [14] [15] [16] [17] [18] [19] [20] [21] [22] In attempting to explain the association between neuroticism and smoking, it was originally proposed either that depressed individuals smoke to relieve negative mood 19 or that smoking cessation leads to depression. 16, 21 However, a study of 1566 female twins found that the association was predominantly due to common familial factors, most likely genetic, that predisposed individuals to both traits. 20 The serotonin transporter, which is encoded by a single gene (SLC6A4) on chromosome 17q12, regulates the magnitude and duration of serotonergic signaling by governing the reuptake of serotonin from the synaptic junction. [23] [24] [25] The promoter region of the serotonin transporter gene contains a 44-bp insertion/deletion polymorphism, termed 5-HTTLPR, that is located ෂ1 kb upstream of the transcription initiation site and influences the expression of this locus at the transcriptional level. 25, 26 Experiments involving cloned fusion genes, cultured lymphoblasts, and postmortem brain tissue have shown that the long (l) allele of the 5-HTTLPR is a more efficient promoter than is the short (s) allele, and that l/l genotype cells produce more serotonin transporter mRNA and protein and take up more serotonin from the medium than do either l/s or s/s genotype cells. [25] [26] [27] Population and family-based behavioral genetic studies have shown that the 5-HTTLPR is associated with neuroticism. Specifically, individuals and siblings with s/l and s/s genotypes scored on average 0.29 standard deviations higher on a standardized scale of neuroticism than did individuals with l/l genotypes. 26 Recently, this observation has been replicated in independent samples in the United States, 28, 29 Japan, 30, 31 and Israel, 32 although not in other populations. 33, 34 The present work investigated the interrelationships between the serotonin transporter gene, neuroticism, and cigarette smoking behavior in a series of sib-pairs that included never, current and former smokers. This design allowed us to examine current smoking status, initiation and cessation by both population association and within-family methods. We tested two alternative hypotheses. The first was that there would be an association between the 5-HTTLPR and smoking behavior; that is, that never smokers, current smokers, and/or former smokers would have different 5-HTTLPR genotype frequencies. This could occur either because the 5-HTTLPR influences neuroticism, which in turn influences smoking behavior, or because the 5-HTTLPR has a direct effect on smoking. Although a previous study failed to find any differences in 5-HTTLPR genotypes in never smokers compared to current smokers, 35 the possible role of the serotonin transporter gene in smoking cessation was not addressed because former smokers were not included in the sample. The second, more speculative hypothesis was that there would be an interaction between the 5-HTTLPR and neuroticism; that is, that smoking behavior would depend on the combination of personality scores and genotype frequencies. This might occur if the serotonin transporter gene polymorphism influenced the type as well as the amount of neuroticism experienced by an individual. We present data that support the second hypothesis and discuss the implications for the development of targeted smoking intervention strategies.
Subjects and methods

Study participants
The study sample consisted of 759 subjects who were ascertained through NIH protocols on Cancer RiskRelated Behaviors (n = 80), Personality Genetics (n = 461), and Sexual Behavior (n = 218). There were 61.5% males and 38.5% females, the average age was 29.2 ± 11.2 years (range 18-73 years), the average educational level was 16.0 ± 2.5 years (range 12-20 years), the average Kinsey score was 1.7 ± 2.5 (range 0-6), and the ethnic composition was 80.6% white non-Hispanic, 5.8% Asian/Pacific Islander, 5.2% Hispanic/Latino, 4.8% African American/black, and 3.7% other. All subjects were members of same-sex sibpairs, of which those in the Cancer Risk-Related Behaviors protocol were selected on the basis of having at least one sibling who was a heavy smoker whereas the remainder were recruited without regard to smoking status.
Smoking and personality assessment
Participants completed a structured interview or questionnaire that stratified them into three categories with regard to smoking status: never smokers (n = 458, 60.3%), current smokers (n = 177, 23.3%), and former smokers (n = 124, 16.3%). Based on detailed smoking inventories administered to 62% of the subjects, current smokers started smoking at 14.9 ± 3.3 years of age, had been smoking for 15.3 ± 12.1 years, and currently smoked 20.3 ± 13.6 cigarettes per day. Former smokers started smoking at 15.9 ± 4.4 years of age, had smoked for 12.1 ± 11.0 years, previously smoked 18.6 ± 12.8 cigarettes per day, and had been abstinent for an average of 10.0 ± 8.6 years at the time of assessment. Never smokers consumed less than 101 cigarettes lifelong, and the majority (68.8%) had smoked less than four cigarettes.
Personality traits were assessed with the NEO-PI-R, 10 a 240-item self-report questionnaire that measures five personality domains, each consisting of six facets. The NEO-PI-R has been demonstrated to have high retest reliability, item validity, longitudinal stability, consistent correlations between self and observer ratings, and a reliable factor structure that was robustly replicated in the present sample.
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Genotyping DNA was extracted from peripheral blood and 5-HTTLPR genotypes were determined by PCR amplification and agarose gel electrophoresis as described. 26 Allele frequencies were 56.5% long (l) and 43.5% short (s), and the genotype frequencies were in Hardy-Weinberg equilibrium (30.8% l/l, 51.4% l/s, and 17.8% s/s). Based on both biochemical expression measurements [25] [26] [27] and psychometric analysis, 26, 28 genotypes were grouped according to whether they were homozygous for the l allele (group L, 30.8%) or were heterozygous or homozygous for the s allele (group S, 69.2%).
Statistical analysis
Effects of personality and 5-HTTLPR genotype on current smoking were assessed by comparing current smokers to never plus former smokers, effects on smoking initiation were assessed by comparing current plus former smokers to never smokers, and effects on smoking cessation were assessed by comparing former smokers to current smokers.
The initial step in the population-based data analysis was to stratify the population by 5-HTTLPR genotype group and compute the Pearson correlations between smoking status, dichotomized as above, and personality test scores. Although Pearson correlations are not often used to analyze such data, in which one of the variables is dichotomous, they are equally valid to and in fact more useful than conventional t-tests or ANOVA for the following reasons: 36 (i) the significance (P value) of the Pearson correlation is exactly the same as the significance of a t-test or ANOVA; (ii) the Pearson correlation is standardized, thereby providing a direct estimate of the magnitude of the linear relationship between two variables, whereas t-test and ANOVA statistics do not provide this information; and (iii) the use of Pearson correlations allows direct comparison to the results of Lerman et al's parallel study. 32 The significances of the differences between genotype-stratified R values were determined by Fisher's Z test:
1/2 . The two-sided significance of Z was determined from the normal distribution.
The data were further analyzed by logistic regression using smoking status, dichotomized as above, as the dependent variable and 5-HTTLPR genotype, personality test score, and 5-HTTLPR genotype × personality test score as the independent variables. Effects of demographic variables (sex, age and ethnic group) were evaluated by adding them as covariates to the regression model. The two-sided significance of the Wald statistic (W) for the 5-HTTLPR genotype × personality test score interaction term was determined from the 2 distribution. The within-family analysis examined the 224 members of all 112 sib-pairs in which one sib had a 5-HTTLPR-L genotype and the other had a 5-HTTLPR-S genotype. Correlation and logistic regression analysis of the data for these 224 subjects, grouped by 5-HTTLPR genotype, was conducted as above, except that Z and W were evaluated as one-sided statistics since the direction was predicted in advance from the population-based data.
Results
Interaction between the 5-HTTLPR and neuroticism
Smoking status, NEO-PI-R personality test scores, and serotonin transporter 5-HTTLPR genotypes were determined in a population of 759 adults that included never, former, and current smokers. The raw data for the neuroticism test scores stratified by both smoking status and genotype are shown in Table 1 . A chi-square test showed that there was no significant association between 5-HTTLPR genotype frequencies and smoking status ( 2 = 0.89, df = 4, P = 0.9). Thus our first hypothesis was not supported. As expected from previous work, 26, 28 there was an association between 5-HTTLPR genotype and levels of neuroticism; the average scores for l/s and s/s genotypes (subsequently referred to as group S) were indistinguishable from one another but both were significantly higher than for l/l genotypes (subsequently referred to as group L). As also expected from prior findings, 6, [11] [12] [13] there was an association between neuroticism and smoking status; the average scores for never smokers and former smokers were indistinguishable from one another but significantly lower than for current smokers. Interestingly, this difference was more pronounced in the S than in the L genotype group, suggesting a gene-personality interaction of the type postulated by our second hypothesis. To initially test for such an interaction, the Pearson correlations between neuroticism and smoking status were computed after stratifying the data by genotype, then analyzed for significant differences between the L and S genotype groups. The Pearson correlation coefficient is a standardized measure of the linear relationship between two variables and ranges from 0 for no relationship to 1 (or −1) for an exact (or exact opposite) linear relationship; it has the same significance level as a t-test or ANOVA (see 'Statistical Analysis' section). The initial analysis focused on the correlation between neuroticism and current smoking by comparing current smokers to never plus former smokers. As anticipated, 6, [11] [12] [13] there was a positive correlation between neuroticism and current smoking in the total dataset (R = 0.145, P = 0.00006), indicating that individuals who currently smoke have higher average neuroticism levels than individuals who do not smoke at present. Stratification of the population by 5-HTTLPR genotype revealed that this relationship was restricted to individuals with poorly expressed 5-HTTLPR-S genotypes ( Table 2 , line 1); specifically, the correlation between neuroticism and current smoking in the S-genotype group was greater than in the total dataset and highly significant (R = 0.19, P = 0.000008) whereas the correlation in the L genotype group was negligible (R = 0.02, P = 0.76). A Fisher Z test showed that there was a significant difference between the correlations in the S and L genotype groups (Z = 2.2, P = 0.03).
The significance of the observed gene-personality interaction was further tested by a multiple logistic regression analysis in which current smoking was the dependent variable and 5-HTTLPR genotype, neuroticism, and 5-HTTLPR genotype × neuroticism were the independent variables. This analysis confirmed that the interaction between 5-HTTLPR genotype and neuroticism was significant (W = 4.9, P = 0.03). Furthermore the 5-HTTLPR genotype × neuroticism interaction term remained significant (W = 4.7, P = 0.04) when age, sex, and ethnic group were included as covariates in the model. The neuroticism scale is comprised of six related facets or subfactors: anxiety, angry hostility, depression, self consciousness, impulsiveness, and vulnerability. Table 2 (lines 2-7) shows that each of these neuroticism facets, except self consciousness, was positively correlated with current smoking in the S genotype group (P = 0.000001 to 0.03) but not in the L genotype group (P Ͼ 0.4). Regression analysis showed that the 5-HTTLPR genotype × personality interaction terms were significant for anxiety, impulsiveness and vulnerability and a trend for depression. These results were confirmed by Fisher Z tests of the genotype-dependent differences in the correlations between these traits and current smoking.
Specificity for neuroticism
To determine whether the observed gene-personality interaction was specific for neuroticism, which has been shown to be influenced by serotonin signaling, we also examined the personality domain of conscientiousness, which includes facets such as self-discipline and deliberation and has been associated with many health-related behaviors. As expected, current smokers were less conscientious than current non-smokers, as indicated by a negative correlation between conscientiousness and current smoking in the total dataset (R = −0.195, P = 0.0000001). However, Table 2 (line 8) shows that for this personality domain, the correlations in the L and S genotype groups were similar, and thus the 5-HTTLPR genotype × conscientiousness interaction term was nonsignificant (P Ͼ 0.5). This demonstrates that the interactive effect of the 5-HTTLPR on smoking behavior is specific for the serotonergic trait of neuroticism.
Comparison of smoking initiation and cessation
To determine whether the 5-HTTLPR-dependent association between neuroticism and its facets with current smoking status was due to effects on smoking initiation, smoking cessation, or both, two additional analyses were performed. Smoking initiation was examined by comparing never smokers to current smokers plus former smokers (ie, ever smokers). Neuroticism was significantly correlated with smoking initiation in the total dataset (R = 0.095, P = 0.009), but the association was weaker than for current smoking. Furthermore, Table 3 (line 1) shows that although the correlation between neuroticism and smoking initiation was significant in the S genotype group (P = 0.006) but not the L genotype group (P = 0.7), there was no significant interaction between 5-HTTLPR genotype and neuroticism for smoking initiation (P Ͼ 0.2). The absence of a significant effect of genotype on the correlation between neuroticism and smoking initiation was confirmed by a Z test (Z = 1.1, P Ͼ 1.2). A similar lack of significant gene-personality interaction for smoking initiation was observed for all of the neuroticism facets and for conscientiousness (Table 3 , lines 2-8).
To study smoking cessation, current smokers were compared to former smokers. Neuroticism was nega- tively correlated with smoking cessation in the total dataset (R = −0.17, P = 0.003), indicating that individuals high in neuroticism have a difficult time quitting smoking, and the absolute magnitude of the correlation was greater than for smoking initiation. Table 4 (line 1) shows that the correlation between neuroticism and smoking cessation was significant in the S genotype group (P = 0.0004) but not the L genotype group (P = 1). Although the absolute difference in the stratified-by- Molecular Psychiatry genotype correlations for smoking cessation was larger than for current smoking (͉R short − R long ͉ = 0.24 for cessation vs 0.17 for current smoking), the significance level for this difference (P = 0.05) was somewhat weaker due to the reduced sample size. The neuroticism facets showed a similar pattern, with the differences in correlations being significant for impulsiveness and trends for anxiety, self consciousness and vulnerability (Table 4 , lines 2-7). Although conscien-tiousness was positively correlated with smoking cessation, there was no interaction with 5-HTTLPR genotype (Table 4 , line 8). These results show that the interactive effects of the serotonin transporter gene and neuroticism on smoking status are primarily at the level of smoking cessation.
Within-family analysis
To examine possible effects of population stratification on the 5-HTTLPR-dependent relationship between neuroticism and smoking behavior, we took advantage of the family structure of the test population to perform a discordant genotype sib-pair test. Specifically, correlations between personality traits and smoking behavior were examined in those 112 sib-pairs in which one sibling had an L genotype and the other had an S genotype, and the significance of the difference in correlations was determined by a Fisher Z test (Table 5) or logistic regression (not shown) with equivalent results. Because each sib-pair is matched for racial/ethnic background, any difference between the L and S genotype groups cannot be due to population stratification.
26 Table 5 (columns 1 and 2) shows that the correlation between neuroticism and current smoking showed a trend to be stronger in the group of siblings with an S genotype than in the group of siblings with an L genotype (P = 0.09). Analysis of the neuroticism facets showed that the differences in correlations between L and S genotype siblings were significant for angry hostility (P = 0.01) and impulsiveness (P = 0.02) and a trend for anxiety (P = 0.07). For smoking initiation, neither neuroticism nor any of its facets showed significant differences in correlations between L and S genotype siblings (Table 5 , columns 3 and 4); indeed, for several of the measures there was a reversal of the direction of the correlations seen in the total population. By contrast, the within-family analysis of smoking cessation showed a striking effect of 5-HTTLPR genotype; the correlation was positive in the L geno- Table 5 Correlations between personality traits and smoking status in members of 5-HTTLPR-discordant sib-pairs Tables 2-4 . Asterisks indicate the significances of the differences in R long and R short as determined by a one-sided Fisher Z test: *P Ͻ 0.1, **P Ͻ 0.05.
type siblings but negative in the S genotype siblings, a significant difference (P = 0.02). A similar pattern was found for the neuroticism subscales, with significant differences in the expected direction for anxiety (P = 0.03), angry hostility (P = 0.02) and impulsiveness (0.01) and a trend for depression (P = 0.08). As expected from the population-based results, the correlations between conscientiousness and smoking status were not influenced by the genotype of the sibling. These results show that the interactive effects of the 5-HTTLPR and neuroticism on current smoking and smoking cessation are not artifacts of population stratification.
Discussion
The initial hypothesis of a measurable association between the 5-HTTLPR and smoking behavior was not supported by the current data or a previous study. 35 Although such an association might have been expected because the 5-HTTLPR influences neuroticism, which in turn affects smoking, the cross product of these two correlations would be too small (R Ϸ 0.02) to observe in a sample size of 759. By contrast, the second, more speculative hypothesis of an interaction between the 5-HTTLPR and neuroticism in smoking behavior was supported. Only individuals with both a weakly transcribed S genotype of the 5-HTTLPR and a high level of neuroticism had an increased risk of smoking and a decreased ability to quit. Analysis of the neuroticism subscales showed the strongest interactions for anxiety-which describes people who are tense, worried, and nervous-and impulsiveness-which refers to an inability to control cravings and urges. 10 These facets help to explain why people often smoke when they feel uncomfortable or upset about something, and why many smokers also have problems with alcohol, drug use, and other addictive behaviors.
Prior to submitting this manuscript, we communi-cated our results to Caryn Lerman and colleagues. Based on our findings, they examined the influence of the 5-HTTLPR and neuroticism on smoking motivations and nicotine dependence in an independent sample of cigarette smokers. 37 Although they could not directly replicate our study design due to a lack of former smokers in their sample, they did find 5-HTTLPRneuroticism interactions with the same direction and magnitude reported by us. Specifically, they found that neuroticism was linked to increased smoking for stimulation, smoking to reduce negative affect, and nicotine intake and dependence in smokers with 5-HTTLPR-S genotypes but not in individuals with 5-HTTLPR-L genotypes. 37 Because self-medication smoking and nicotine dependence are well known predictors of difficulty in quitting smoking, [13] [14] [15] [16] [17] [18] [19] 22 Lerman et al's results support our finding of a gene-personality interaction for smoking cessation. The combined results of the two studies suggest that individuals with a poorly expressed serotonin transporter gene and high neuroticism have a roughly average chance of initiating smoking, but that once they have started they are at increased risk of becoming addicted to nicotine and therefore find it more difficult to quit.
Our results suggest that in individuals with a highly expressed 5-HTTLPR-L genotype, neuroticism is not an important impediment to smoking cessation. Even though many of these individuals are anxious, impulsive and vulnerable to stress, they are no more and no less likely to smoke than are L-genotype individuals who consider themselves to be calm, cautious and resilient. Perhaps this type of neuroticism is primarily the result of non-serotonergic genetic pathways or of environmental, social or psychological factors that are not amenable to self-medication by nicotine. By contrast, in individuals with a poorly expressed 5-HTTLPR-S genotype, neuroticism is a significant risk factor for smoking. Individuals with an S genotype who score high for anxiety, impulsiveness and other facets of neuroticism are more likely to be smokers than are S genotype individuals who are low on these traits, mostly because they are less likely to quit once having started. Perhaps this form of neuroticism often leads to nicotine self-medication and addiction because it is caused by an alteration in serotonin pathways that interact with the nicotine system.
The clinical implication of these findings is that 5-HTTLPR genotype, in combination with personality measures, may predict the efficacy of different smoking cessation drugs and strategies. Because the serotonin transporter is primarily a modulator of serotonergic signaling and tone, it would seem most likely to influence the utility of serotonergic drugs such as the specific serotonin reuptake inhibitors. Preliminary studies suggest that fluoxetine is most useful as a smoking cessation drug in a subset of depressed smokers; 38, 39 perhaps further specificity could be achieved by combining measures of depression with 5-HTTLPR genotype. There is increasing evidence that serotonin also interacts the mesolimbic dopamine pathways that are critical for the rewarding and reinforcing properties Molecular Psychiatry of nicotine and other drugs. [40] [41] [42] [43] [44] This suggests that 5-HTTLPR genotype could also play a role in responsiveness to dopaminergic smoking cessation drugs such as bupropion. 45 Finally, 5-HTTLPR genotype could be used to predict which individuals would most benefit from behavioral therapies, such as cognitive-behavioral mood management, 46 rather than pharmacological intervention. The molecular genetic analysis of the psychiatric diagnoses of nicotine dependence and withdrawal is at an early stage. We hope that this report will stimulate further research in this area and ultimately lead to prospective clinical trials in which 5-HTTLPR and other genotypes are used to stratify the test population.
